UPR 5301

Creation of the new start-up resulting from the work of Cermav, AIS Biotech

26 May 2023

AIS Biotech relies on innovative, efficient, industrializable biotechnology with low environmental impact, to develop a new class of anti-infective biomedicines. Click on the title for more information.

The technology licensed to AIS Biotech is based on the historical work of Cermav, which was matured in collaboration with the CIRI laboratory in Lyon thanks to funding from SATT Linksium.

It is highlighted in CNRS Innovation Letter.

Other news

AIS BIOTECH is one of the 100 start-ups to invest in, according to Challenges magazine in 2024 !

2 April 2024

Lire la suite »

Scientific and Technical Day of the Carnot Network – Biosourced Products for the Bioeconomy!

12 March 2024

Lire la suite »

6th FBPOL2024 – French Brazilian Meeting on Polymers: Bridging Innovation and Collaboration in Polymer and Bio(Material) Science

28 February 2024

Lire la suite »

2024 PolyNat international industries forum

28 February 2024

Lire la suite »

Redox-responsive maltoheptaose-b-polystyrene nanoparticles containing zinc phthalocyanine: Formulation, photophysical properties, release kinetic and toxicity

15 February 2024

Lire la suite »